mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal read alignment evidence (highest frequency 20 of 115 shown, sorted by frequency from high to low) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
| * | NZ_CP009273 | 1,624,829 | 0 | T | C | 63.3% | 23.1 / 31.0 | 30 | E114E (GAA→GAG) | ydfI | mannitol dehydrogenase family protein |
| * | NZ_CP009273 | 360,762 | 0 | T | G | 62.5% | 10.8 / 16.4 | 16 | T328P (ACC→CCC) | lacI | DNA‑binding transcriptional repressor LacI |
| * | NZ_CP009273 | 3,659,062 | 0 | C | A | 61.1% | 4.1 / 23.1 | 36 | A37S (GCG→TCG) | gadX | acid resistance transcriptional activator GadX |
| * | NZ_CP009273 | 3,406,257 | 0 | C | T | 58.8% | ‑5.9 / 14.9 | 17 | A190T (GCC→ACC) | acrS | multidrug efflux transporter transcriptional repressor AcrS |
| * | NZ_CP009273 | 2,342,624 | 0 | A | C | 58.3% | 4.6 / 13.1 | 12 | F110V (TTC→GTC) | inaA | lipopolysaccharide kinase InaA |
| * | NZ_CP009273 | 49,903 | 0 | T | A | 58.1% | 14.3 / 38.7 | 31 | D27E (GAT→GAA) | folA | type 3 dihydrofolate reductase |
| * | NZ_CP009273 | 1,780,586 | 0 | A | G | 58.1% | 5.9 / 40.6 | 31 | S262P (TCG→CCG) | ppsA | phosphoenolpyruvate synthase |
| * | NZ_CP009273 | 744,103 | 0 | T | C | 57.1% | 1.8 / 13.6 | 14 | G112G (GGA→GGG) | ybgO | fimbrial protein |
| * | NZ_CP009273 | 1,844,336 | 0 | T | C | 57.1% | ‑1.8 / 16.5 | 14 | S415P (TCC→CCC) | sppA | signal peptide peptidase SppA |
| * | NZ_CP009273 | 655,396 | 0 | T | A | 56.2% | 5.4 / 20.7 | 16 | I93F (ATT→TTT) | lipA | lipoyl synthase |
| * | NZ_CP009273 | 3,406,265 | 0 | T | A | 56.2% | ‑1.6 / 17.0 | 16 | Y187F (TAT→TTT) | acrS | multidrug efflux transporter transcriptional repressor AcrS |
| * | NZ_CP009273 | 3,659,058 | 0 | T | C | 55.3% | 6.9 / 41.5 | 38 | D38G (GAT→GGT) | gadX | acid resistance transcriptional activator GadX |
| * | NZ_CP009273 | 3,708,979 | 0 | T | C | 54.8% | ‑0.3 / 44.5 | 31 | E259G (GAA→GGA) | bisC | biotin sulfoxide reductase |
| * | NZ_CP009273 | 289,256 | 0 | T | C | 54.5% | ‑1.2 / 28.9 | 22 | D125G (GAC→GGC) | yagL | recombinase family protein |
| * | NZ_CP009273 | 2,145,054 | 0 | A | T | 54.5% | ‑1.8 / 10.4 | 11 | Y130F (TAT→TTT) | yegJ | DUF2314 domain‑containing protein |
| * | NZ_CP009273 | 303,532 | 0 | G | T | 53.8% | 6.5 / 16.5 | 13 | Y504* (TAC→TAA) | ecpC | fimbrial usher EcpC |
| * | NZ_CP009273 | 1,018,393 | 0 | T | C | 53.8% | 7.3 / 16.4 | 13 | E319G (GAG→GGG) | yccS | YccS family putative transporter |
| * | NZ_CP009273 | 612,012 | 0 | T | G | 53.3% | 10.7 / 21.4 | 15 | G800G (GGT→GGG) | entF | enterobactin non‑ribosomal peptide synthetase EntF |
| * | NZ_CP009273 | 1,472,581 | 0 | T | G | 52.9% | 13.3 / 24.2 | 17 | G33G (GGT→GGG) | ynbB | phosphatidate cytidylyltransferase |
| * | NZ_CP009273 | 324,502 | 0 | A | G | 52.6% | 10.2 / 25.4 | 19 | S182P (TCC→CCC) | betI | transcriptional regulator BetI |